Мировой рынок лечения балантидиаза — тенденции отрасли и прогноз до 2028 года

Анализ рынка и идеи : мировой рынок лечения балантидиаза

Ожидается, что рынок лечения балантидиаза будет расти в прогнозируемый период 2021-2028 гг. Data Bridge Market Research анализирует рынок, чтобы учесть среднегодовой темп роста (CAGR) в размере 5,3% в указанный выше прогнозируемый период.

Балантидиаз относится к заболеванию, которое вызывается Balantidium coli. Это одноклеточный кишечный паразит, передающийся фекально-оральным путем. Люди могут заразиться паразитом, проглатывая инфекционные цисты из зараженной пищи и воды во время дефекации. В основном этим заболеванием поражается толстый кишечник. Балантидиаз также называют инфекцией Balantidium coli. Это расстройство характеризуется потерей веса, мышечной слабостью, диареей, головной болью , рвотой, дизентерией, бессонницей и болью в желудке.

Рост распространенности балантидиаза, рост числа случаев желудочно-кишечных расстройств и рост расходов на здравоохранение являются основными факторами, влияющими на темпы роста рынка. Кроме того, прогресс в области медицинских технологий, рост государственного финансирования и растущие инициативы государственных и частных организаций по распространению информации о заболевании и доступных вариантах его лечения являются факторами, которые расширят рынок лечения балантидиаза. Кроме того, злоупотребление алкоголем и рост тенденции свиноводства являются рыночными драйверами, которые смягчат темпы роста рынка.

Рост научно-исследовательской деятельности в области диагностики заболеваний и появление новых рынков откроют благоприятные возможности для рынка лечения балантидиаза в прогнозируемый период 2021–2028 гг.

However, high cost associated with the treatment and rising competition amongst existing market players are the factors that will hinder the market growth. Lack of hygiene and sanitization in rural areas of developing nations will further challenge the balantidiasis treatment market in the forecast period mentioned above.

This balantidiasis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the balantidiasis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Balantidiasis Treatment Market Scope and Market Size

The balantidiasis treatment market is segmented on the basis of treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the balantidiasis treatment market is segmented into tetracycline, metronidazole, iodoquinol, appendectomy and others.
• On the basis of diagnosis, the balantidiasis treatment market is segmented into microscopy stool examination, biopsy, sigmoidoscopy and others.
• On the basis of symptoms, the balantidiasis treatment market is segmented into weight loss, muscle weakness, diarrhea, headache, vomiting, dysentery, insomnia, stomach pain and others.
• On the basis of dosage, the cronobacter market is segmented into tablet, injection and others.
• On the basis of route of administration, the balantidiasis treatment market is segmented into oral and intravenous.
• On the basis of end-users, the balantidiasis treatment market is segmented into clinic, hospital and others.

The balantidiasis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Balantidiasis Treatment Market Country Level Analysis

Balantidiasis treatment market is analyzed and market size information is provided by the country, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the balantidiasis treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the balantidiasis treatment market due to major key players, high healthcare expenditure and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector, changing lifestyle and growing prevalence of chronic diarrhea, colitis and deep intestinal ulcerations in this region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Balantidiasis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Balantidiasis Treatment Market Share Analysis

Balantidiasis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to balantidiasis treatment market research.

Основными игроками, охваченными отчетом о рынке лечения балантидиаза, являются GENERAL ELECTRIC, Koninklijke Philips NV, 3M, Apotex, Inc. BD, Pfizer Inc., Abbott, Sanofi, Allergan, Johnson & Johnson Private Limited, Siemens Healthcare GmbH, Sonova, MicroPort Scientific Corporation, NuVasive, Inc., GlaxoSmithKline plc, Zhejiang Nurotron Biotechnology Co., Ltd., Akorn Operating Company LLC, Amneal Pharmaceuticals LLC, а также другие отечественные и мировые игроки. Данные о доле рынка доступны для Глобального региона, Северной Америки, Европы, Азиатско-Тихоокеанского региона (APAC), Ближнего Востока и Африки (MEA) и Южной Америки отдельно. Аналитики DBMR понимают конкурентные преимущества и предоставляют конкурентный анализ для каждого конкурента отдельно.

SKU-66976